The Newest and Revolutionary Technology for Increasing Investor Visability.
REAL Awareness for REAL Companies.
Click below for a full demonstration.
http://newmediaadvisors.info/newmedia.swf
Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com
Nov 10, 2008 -- Envit Capital Group, Inc., (PINKSHEETS: ECGP | Quote | Chart | News | PowerRating) is pleased to announce that its Board of Directors will authorized a series of private transactions to reduce the outstanding shares of the company by 30 Million.
In the transactions that lead up to the Reverse Merger of The Envit Capital Group, Inc., and Fortel, Inc., the CEO and Chairman Edward M. Laborio had acquired 200,000 of the outstanding 300,000 convertible preferred shares, convertible at a 100:1 ratio, equating to 30,000,000 shares. These shares are due to convert into common shares shortly and the Board of Directors has made the decision to prevent any further dilution of the outstanding shares by returning all of the shares to its treasury.
Envit Capital believes that the stock price does not reflect the growth of the Company and will continue to take measures to reduce the amount of the outstanding shares of the company. Envit Capital will continue these aggressive measures in order to reach the company's EPS goal in the next fiscal year.
CEO & Chairman, Edward M. Laborio said, "The Board of Directors is currently evaluating the current outstanding share structure and is exploring the possibility of reducing additional outstanding Shares".
About Envit Capital Group, Inc.
The Envit Capital Group, Inc., (Envit Capital) is a development stage boutique investment banking, securities and investment management firm that will provide a range of services to a client base that will include business, institutions, and high-net-worth individuals. Its objective is to be active in all three of the following segments: Investment Banking, Trading and Principal Investments, and Asset Management and Securities Services.
Nov 10, 2008 -- General Motors Corp. (NYSE: GM). Unified Government Mayor Joe Reardon announced today that a retired General Motors executive will review business practices at the beleaguered Board of Public Utilities.
George Turner, recently retired from General Motors' Fairfax plant as its chief financial officer, will conduct what the Unified Government describes as a "fact-finding mission to review BPU business and management practices." Turner, who also has served as chairman of the Kansas City Kansas Area Chamber of Commerce, will report his findings to the Unified Government, which owns the BPU, sometime in January.
Reardon made the announcement during an afternoon news conference that came about a month after Marc Conklin, the BPU's chief administrative officer, and Rod Turner, a lawyer who consults for the BPU, were charged with stealing nearly $400,000 from the utility.
It also comes after the utility has had to defend itself in recent years against allegations of nepotism, excessive charges to utility credit cards and allegations that the BPU violated the federal Clean Air Act.
Last month's charges, Reardon said, "reflect directly on the management of the utility." Although he said the legal process would determine the guilt or innocence of those charged, Reardon acknowledged that the charges had raised concerns with citizens and ratepayers.
"As mayor, I too am concerned," Reardon said, noting that he had already asked the Unified Government's legislative auditor to examine the utility's procurement and payment processes.
"I believe this was a prudent first step, but more needs to be done to review and ensure for the Unified Government and our citizens that the utility is using best practices in its business operations and that the management of the utility is acting in a way that puts the best interests of the citizens at the forefront."
The Unified Government has allocated $30,000 for George Turner's services, and the BPU will provide an office for him to work in.
After the news conference, BPU board President Loretta Colombel and General Manager Don Gray said they welcomed George Turner's review.
Colombel said she was "happy the mayor has done this" and that she thinks the review would find good things. She noted that the BPU has maintained strong credit ratings, that the utility charges competitive rates and that it has been nationally recognized for its performance.
Reading from a prepared statement, Colombel called George Turner's review "another opportunity to demonstrate that many perceptions about the BPU are based on past practices that we have revised, and that we seek continuous improvement."
But when asked what some of those practices are, Colombel could not name them. She said the BPU was looking at changing policies. Gray later added that some of those changes would affect various services, including legal, pesticide control and janitorial.
Nov 11, 2008 -- Interact Holdings Group, Inc. (PINKSHEETS: IHGR | Quote | Chart | News | PowerRating) announced today it has finalized the terms with LUUMS International to become the exclusive distributor of LUUMS LED product lines in the United States for no less than 5 years.
The Company had announced on October 1st, 2008 that it had signed a Memorandum of Understanding to become the exclusive distributor of LUUMS' products in the U.S. marketplace. Since then, both parties have worked diligently to finalize the agreement.
The LED market continues to grow and is on pace to exceed the $4.6 billion mark in 2008. Interact Holdings Group, Inc. has reshaped its business to primarily focus on business and revenue streams which promote "green" and "earth-friendly" products and services.
"As President, it is with great satisfaction that I announce the culmination of many hours of diligence that has brought about the finalization of the paperwork necessary to create this exclusive U.S. Distributorship of LUUMS LED Products. This partnering is the mortar that will set the lynch pin of our foothold in the Eco-Responsible, Earth-Friendly Product Marketplace. I will be working closely with Mr. Sleurink (LUUMS International B.V.), to bring our Companies and their product to the forefront of the Residential, Commercial, and Construction Market," said William Yates, President of Interact Holdings Group, Inc.
"Due to our continuous desire to make environmentally friendly LUUMS LED technologies widely accessible, we are always searching for international partnerships. We trust that LUUMS will become a leader in the American LED market through Interact Holdings Group, Inc.'s exclusive distributorship," said Edwin Sleurink, Managing Partner at LUUMS International B.V.
Nov. 11, 2008 -- Javo(r) Beverage Company, Inc. (OTCBB: JAVO), a leading provider of premium dispensable coffee and tea-based beverages to the food service industry, announced today its unaudited financial results for the third quarter of 2008.
Financial highlights for the third quarter ending September 30, 2008 include the following:
* Revenues increased 45% to $5.6 million from $3.9 million in the third quarter 2007.
* Gross profit margin expanded to 40.3%, an increase of 1,230 basis points from the year ago period.
* The Company's total base of beverage dispensers reached 9,345, an increase of 519 from the prior quarter in line with forecast.
* Dispensed products revenue reached $4.3 million, up 51% over third quarter 2007.
* Selling, general and administrative expenses totaled $4.7 million, an increase of 63% versus the year ago period, due primarily to larger non-cash expenses and higher variable marketing expenses related to the Company's national account programs.
* The Company had a net loss of $2.6 million compared to a loss of $127 thousand in the prior year quarter. The difference of $2.6 million was attributable to a reduction in non-cash derivative income of $2.0 million and additional non-cash expense increases for depreciation, amortization and stock compensation.
Financial highlights for the first nine months ending September 30, 2008 include the following:
* Revenues increased 65% to $16.2 million from $9.8 million in the third quarter 2007.
* Gross profit margin expanded to 43.1%, an increase of 920 basis points from the year ago period.
* The Company's total base of beverage dispensers reached 9,345, an increase of 5,040 since the beginning of the year.
* Dispensed products revenue reached $12.8 million, up 105% over the first nine months of 2007.
* Selling, general and administrative expenses totaled $11.6 million, an increase of 48%, primarily due non-cash items, expenses associated with fielding the Company's national sales force and higher variable marketing expenses for national programs.
* The Company had a net loss of $6.7 million compared to a loss of $5.4 million in the prior year quarter. The difference of $1.3 million was entirely accounted for by the reduced non-cash derivative income for the period versus year ago.
Cody C. Ashwell, chairman and CEO of Javo Beverage Company, said, "Javo's third quarter results and year-to-date performance demonstrate the superiority of Javo's product proposition compared to its competitors and the strength of our business model, especially in this difficult economic environment. The Company stayed on target with respect to our 2008 business plan, so far adding 5,040 new recurring revenue dispensing locations and leaving us within reach of our year-end target of 10,000 dispenser placements."
Ashwell continued, "Our dispensed specialty beverage platform gives the 2.5 million traditional foodservice locations across the country the ability to deliver coffee shop-style beverages in a convenient, high quality platform at a time when consumers are looking for value oriented alternatives for many of their daily purchases. When a foodservice location installs and maintains a Javo hot coffee or specialty beverage dispenser in their restaurant, hospital, hotel, convenience store or casino it creates a predictable monthly revenue stream for Javo who supplies the beverage concentrates for that equipment. Reaching the 10,000 dispenser milestone means that we enter 2009, without any additional growth, with an annual revenue run rate in excess of $ 35 million, above our annual operating breakeven with current overhead."
Ashwell added, "Our operations group, which recently managed the integration of coffee roasting and certain key processing and packaging operations at our brewing facility in Vista, achieved a gross margin of 40.3% for the quarter, 12 full percentage points above year ago. This investment in our manufacturing operations eliminated several third party manufacturing operations, reduced inter-plant freight and improved the overall efficiency of our beverage production operations. The margin performance was lower versus the prior quarter was due to an expected shift in product mix to packaged and bulk coffee products."
Ashwell said, "Selling, general and administrative expenses, which have been scaled to support a fully national customer base and selling force, were $4.7 million, compared to $ 2.9 million in the same quarter in 2007. The $1.8 million increase was due, primarily, to increases in non-cash expenses for depreciation and amortization of $476 thousand and stock compensation issuance of $378 thousand. Selling costs for the third quarter were higher by $ 896 thousand versus year ago with $ 619 thousand attributable to planned variable marketing allowances tied to our growing national account business. The remainder of the increase was tied to the expansion of our sales force to better capitalize on customer opportunities in key geographic areas. Our general and administrative costs have stabilized and excluding non-cash items, were nearly identical with year ago."
Ashwell concluded, "We recorded a $2.7 million net loss for the third quarter versus a loss of $ 128 thousand in the same quarter of 2007. The difference of $ 2.6 million was attributable to a reduction in non-cash income from derivatives due to liability accounting for warrants of $2.0 million and additional non-cash expense increases for depreciation, amortization and issuance of stock for compensation of $ 852 thousand."
Gary Lillian, president of Javo Beverage Company, said, "Javo's sales team continued to execute at a high level during challenging economic times, adding 519 on-demand beverage dispensing locations, bringing our total to 9,345. In line with the anticipated seasonality of our beverage business, we shifted our selling focus during the quarter from our iced coffee products, to hot coffee placements with our growing base of approved national programs, such as Premier Healthcare, the Department of Veterans Affairs, Compass Group, Amerinet and MedAssets Supply Chain Systems. Each new location adds a predictable product revenue stream over the following twelve month period of between $2,500 and $5,500."
Lillian added, "We have not seen a meaningful impact from the downturn in the economy on coffee orders for installed dispensers. During the spike in gas prices in July and August, however, we did encounter convenience store retailers being cautious about the introduction of new products and programs. In some cases, this hesitance resulted in test program or chain-wide expansion delays that negatively impacted Javo's third quarter. As gas prices have eased off their peaks, these program roll-outs have resumed without any loss in business potential. Aside from the unusual circumstances of the last several months, our business has demonstrated itself to be relatively insulated from economic cycles. The key reason is that, even though consumers may seek out less costly ways to source their coffee, they typically do not reduce daily consumption when tightening their belts. Furthermore, our largest customer sector is healthcare, where we expect stable or even growing patient and staff populations over the middle and long term. Regardless of the economic climate, Management believes Javo has an expansive opportunity for continued growth in market share within the $7 billion U.S. market for foodservice coffee and tea especially in which operators are increasingly converting from traditional to dispensed beverage platforms." Management of Javo Beverage will host a conference call Wednesday, November 12, 2008 at 11:00 a.m. EST to discuss the company's financial results and achievements. Those who wish to participate in the conference call may telephone (866) 682-6100 from the U.S. or (201) 499-0416 for international callers. A digital replay of Wednesday's conference call will be available by telephone approximately 2 hours after the completion of the call. It wil be available for 30 days and may be accessed by dialing (888) 346-3949 from the U.S., or (404) 260-5385 for international callers. At the prompt, dial pin code "5401081" followed by "4" to listen a previously recorded conference followed by confirmation number "20081110190485". If you experience technical difficulties connecting to the conference call, please dial (760) 560-5286 ext. 102 for assistance.
About Javo(r) Beverage Company, Inc.
Based in Vista, California, Javo(r) Beverage Company (OTCBB:JAVO) is an innovator and leader in the manufacture of coffee and tea-based dispensed beverages, drink mixes and flavor systems. The company has successfully commercialized a proprietary brewing technology that yields fresh brewed coffees and teas that are flavorful, concentrated and stable, with broad applications in the food service, food manufacturing and beverage industries. For food service operators, Javo makes it possible to serve great tasting hot coffees and cold specialty coffee beverages from convenient dispenser-based systems. Javo also assists food and beverage processors seeking authentic and robust coffee and tea flavors through its development and supply of customized ingredients for packaged foods and ready-to-drink beverages. The company supplies a growing list of national and international food service operations, specialty coffee retailers, restaurant chains and food manufacturers.
JAVO BEVERAGE COMPANY, INC.
JAVO BEVERAGE COMPANY, INC. CONDENSED BALANCE SHEETS
September 30, 2008 December 31, Unaudited 2007
-------------------------------
ASSETS
Current assets:
Cash and cash equivalents $ 372,346 $ 6,636,908
Restricted cash 4,777,000 3,863,000
-------------------------------
Total cash, restricted cash and cash equivalents 5,149,346 10,499,908
Accounts receivable, less allowances 2,711,006 1,481,924
Inventory, net of reserve for obsolescence 1,086,231 691,420
Prepaid expenses 237,992 293,025
-------------------------------
Total current assets 9,184,575 12,966,277
Property and equipment, net 9,500,899 4,644,993
Intangibles, net 805,433 750,060
Deposits 23,858 20,242
-------------------------------
Total assets $19,514,765 $18,381,572
===============================
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities: Accounts payable and accrued expenses $ 6,191,340 $ 2,024,062
Accrued payroll and related benefits 201,574 139,358
Accrued short-term interest payable 267,754 399,808
Working capital line of credit 4,777,000 3,863,000
Warrants payable 557,690 2,389,215
Current portion of long-term debt and capital leases 4,830,614 4,990,563
------------------------------- Total current liabilities 16,825,972 13,806,006
Long-term debt and capital leases, net of current portion 9,892,196 13,587,773
Unamortized discount on long-term debt (6,214,871) (9,216,562)
Accrued long-term interest payable 72,497 52,444
-------------------------------
Total liabilities 20,575,794 18,229,661
Commitments and contingencies -- --
Stockholders' equity (deficit): Preferred stock, $0.001 par value, 10,000,000 shares authorized, 2,147,951 shares issued and outstanding as of September 30, 2008, and 1,952,683 as of December 31, 2007 2,148 1,953
Common stock, $0.001 par value, 300,000,000 shares authorized, 161,980,266 shares issued and outstanding as of September 30, 2008, 153,378,797 shares issued and outstanding as of December 31, 2007 161,980 153,379
Additional paid in capital 59,937,281 53,549,821
Deferred compensation (2,938,764) (4,023,653)
Accumulated deficit (58,223,674) (49,529,589)
-------------------------------
Total stockholders' equity (deficit) (1,061,029) 151,911
-------------------------------
Total liabilities and stockholders' equity $19,514,765 $18,381,572
===============================
JAVO BEVERAGE COMPANY, INC. CONDENSED STATEMENT OF OPERATIONS UNAUDITED
Three Months Ended Nine Months Ended September 30, September 30, 2008 2007 2008 2007
--------------------------------------------------
Net sales $ 5,636,101 $ 3,898,985 $16,169,911 $ 9,807,252
Cost of sales (3,365,333) (2,807,636) (9,202,085) (6,486,084)
--------------------------------------------------
Gross profit 2,270,768 1,091,349 6,967,826 3,321,168
Operating expenses: Selling and marketing (2,072,451) (1,176,101) (5,304,537) (3,022,781)
General and administrative* (2,602,931) (1,698,928) (6,318,972) (4,828,063)
--------------------------------------------------
Total operating expenses (4,675,382) (2,875,029) (11,623,509) (7,850,844)
--------------------------------------------------
Loss from operations (2,404,614) (1,783,680) (4,655,683) (4,529,676)
--------------------------------------------------
Other income (expenses):
Interest income 32,487 186,806 135,092 560,849
Interest expense** (1,305,436) (1,540,071) (4,083,279) (4,720,716)
Income (expense) from derivatives*** 990,050 2,998,898 1,831,525 3,263,206
Other income 271 11,746 40,941 42,849
Loss on disposal of assets 3,441 (1,427) (10,000) (2,604)
--------------------------------------------------
Total other income (expense) (279,187) 1,655,952 (2,085,721) (856,416)
--------------------------------------------------
Net loss $(2,683,801) $ (127,728) $(6,741,404) $(5,386,092)
==================================================
Basic loss per share $ (0.017) $ (0.001) $ (0.043) $ (0.036)
================================================== Weighted average number of shares outstanding, basic 155,966,182 150,889,106 157,975,375 150,013,683
==================================================
* For the three and nine months ended September 30, 2008, general and administrative expenses include non-cash option expense of $361,630 and $1,245,435, non-cash compensation stock issuance expense of $378,000 and non-cash depreciation and amortization expense of $594,810 and $1,084,890, respectively.
** For the three and nine months ended September 30, 2008, interest expense of $1,305,436 and $4,083,279 includes non-cash accretion of debt discount of $942,674 and $2,979,191. In addition, interest expense included accrued interest on its Senior Convertible Debt of $256,722 and $830,023 which was paid with common stock. Excluding the non-cash accretion of debt discount and the accrued interest converted to common stock, the Company's interest expense for the third quarter 2008 was $106,040 and $274,065.
*** For the three and nine months ended September 30, 2008, expense from derivatives is a non-cash income related to change in Black-Scholes value of warrants to purchase 7,195,844 shares of the Company's Common Stock. The warrants have strike prices ranging from $1.79 to $2.24 per share and expire on December 15, 2011. The Company would receive an additional $14.9 million in equity capital if these warrants were exercised in full at the current strike prices.
Nov 11, 2008 -- Oxygen Biotherapeutics, Inc. (OTCBB: OXBO | Quote | Chart | News | PowerRating) today announced that a study published in the October 2008 edition of the journal Neurosurgery demonstrates that Oxycyte(R) can improve cognitive recovery and has a protective effect on hippocampal neurons in an experimental Traumatic Brain Injury (TBI) model in rats. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
The investigators in the study and authors of the article are Zhengwen Zhou, M.D.; Dong Sun, M.D., Ph.D.; Joseph E. Levasseur, M.S.; Amedeo Merenda, M.D.; Robert J. Hamm, Ph.D.; Jiepei Zhu, Ph.D.; Bruce D. Spiess, M.D.; of Virginia Commonwealth University and M. Ross Bullock, M.D., Ph.D. who is with the University of Miami, Miller School of Medicine.
In the study, test animals were divided into two groups and treated with either a low dose or a high dose of Oxycyte and breathed 100 per cent oxygen after an induced injury. Control animals were given saline.
The researchers found that injured animals treated with a lower or higher dose of Oxycyte had significant improvement in ability to learn and function in a standard maze when compared with injured saline control animals. The ability to learn and perform complex tasks (a maze) are the ultimate tests of higher brain function. Moreover, injured animals that received either dose of Oxycyte had significantly less brain damage compared with saline-treated animals. They also found that a lower dose of Oxycyte significantly improved cells' ability to process and use oxygen.
"This study lends additional weight to what we believe about the potential benefits of Oxycyte in TBI. If Oxycyte can provide improved cognitive function in TBI patients, it can make a huge difference in their recovery and quality of life," said company chairman and CEO Chris J. Stern, DBA. "As we've previously announced, we intend to submit an amended test protocol to the FDA to cover dose escalation studies of Oxycyte in TBI. This latest published animal study suggests that a lower dose of Oxycyte may have the same benefit as a larger one. The next round of clinical trials should tell us."
The new studies will be designed as multi-center studies focusing on finding the lowest dose of Oxycyte that reduces the platelet reduction (thrombocytopenia) and still provides clinical benefit in traumatic brain injury. Both studies will additionally be designed to study the widely unexplored correlation between platelets/thrombocytopenia and the scientific reasons why perfluorocarbons can cause such an effect. Knowing the mechanism behind any platelet drop could have the potential to solve a number of unresolved problems in other drugs.
Due to the slight redesign of the protocol and regulatory and administrative processes, patient enrollment is anticipated to begin in the first quarter of 2009.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The Company has under development a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis pain, trauma, wound care, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, and diabetes.
Nov 11, 2008 -- SpongeTech(R) Delivery Systems, Inc. (OTCBB: SPNG | Quote | Chart | News | PowerRating) is pleased to announce that its CEO and President, Michael Metter, will be interviewed today on Steve Crowley's American Scene Radio Show at 9:24 a.m. EST. The interview can be heard live on BusinessTalkRadioNetwork(R) affiliate radio stations streamed on its website, www.businesstalkradio.net. You can find local radio stations by accessing the website, as well. Mr. Metter will be scheduled for future interviews on American Scene, where he will keep listeners updated on SpongeTech(R)'s products and developments.
About SpongeTech(R) Delivery Systems, Inc.
SpongeTech(R) Delivery Systems is a company which designs, produces, and markets a unique line of reusable cleaning products for household use. These sponge-based products utilize SpongeTech(R)'s Proprietary, patent (and patent- pending) technologies involving hydrophilic (liquid absorbing) foam and polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, the latter of which comes pre-loaded with specially formulated soaps and wax that are released when the sponge is wetted and applied to a surface with minimal pressure. The Company's current product line is designed for Car Care and Pet Care, however, SpongeTech(R) is currently exploring additional applications for its technology including an anti-bacterial, kitchen and bath cleaner, as well as a unique "foaming" bath sponge for children.
About Standoutstocks.com
Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx
CONTACT: Standoutstocks.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index